Not Tagged
Not Tagged
['leukemia', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'myeloid']
at the 2023, early results from the first-in-human study of sar443579 in relapsed or refractory acute myeloid leukemia (aml), b-cell acute lymphoblastic leukemia, or high-risk myelodysplasia have revealed positive results. visit for more details: 
#DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry